ContentsThe purpose of this study was to define (i) the interval between treatment and sterility, and (ii) semen quality in male dogs administered a 4.7-mg deslorelin implant. Six healthy, adult dogs of various breeds and body weights were implanted with deslorelin (Suprelorin, Virbac) and followed every 2 weeks with semen and blood collections. Semen quality remained stable or even improved during the first month following treatment and then showed a progressive decline until the end of the study, except for sperm morphology, which was unaffected by the treatment. Complete sterility was achieved on post-treatment days 70, 84, 60, 23, 51 and 40 for dogs 1 to 6, respectively. The 4.7 mg deslorelin implant caused a significant (p < 0.05) decrease in serum testosterone as well as sperm motility. Our results (i) confirm the efficacy of deslorelin in causing reversible sterility in male dogs, (ii) confirm and provide details about endocrine and seminal parameters involved in this process and (iii) contribute to define the interval between treatment and achievement of complete sterility. Practitioners should be aware that such interval may be longer than 2 months in some cases, and that fertility may actually be increased during the first 2-4 weeks post-treatment.
RESUMENEl síndrome de ovario remanente es una complicación conocida y de larga duración de la ovariectomía u ovariohisterectomía, que es causada por la presencia de tejido ovárico activo a pesar de una cirugía electiva. Como resultado de dejar restos de tejido ovárico en el abdomen o debido a la presencia de tejido ovárico ectópico, se desarrollan signos clínicos típicos de proestro o estro tales como hinchazón de la vulva, sangramiento o cambios conductuales. El diagnóstico se realiza por citología vaginal, medición de hormonas gonadales, ultrasonografía y cirugía exploratoria. La excisión quirúrgica de la masa ovárica es el tratamiento recomendado, lo cual es un proceso difícil. Este trabajo describe las causas del síndrome, los signos clínicos del paciente, el diagnóstico y el tratamiento del síndrome de ovario remanente en perras.Palabras clave: perro, ovariohisterectomía, estro postoperación, sangramiento vaginal
In the current study, a total of 90 mammary neoplasms obtained from 55 female dogs were used to determine the accuracy of fine-needle aspiration cytology in the diagnosis of canine mammary tumours and to investigate the feasibility of this technique for the differentiation of simple tumours from complex or mixed tumours. Three aspirations were performed on each mammary gland mass using a 22-gauge needle attached to a 5-ml syringe before the mammary glands were surgically excised and submitted for histopathological examination. Twenty-five (27.7%) of 90 samples were classified as insufficient/inadequate for diagnosis. Of the remaining 65 samples, six (9.2%) were benign, 51 (78.5%) were malignant tumours and 8 (12.3%) were suspicious. Histopathological examination of the 90 specimens revealed five (5.6%) benign, 84 (93.3%) malignant and one (1.1%) non-neoplastic lesion. The diagnostic accuracy, sensitivity and specificity of cytologic examination for diagnosing malignancy were 96.5%, 96.2% and 100%, respectively. However, when inadequate (n = 25) and suspicious (n = 8) samples were included, the diagnostic accuracy and sensitivity decreased to 63.3% and 60.7%, respectively, but no change was observed in the specificity. Furthermore, it was not possible to differentiate simple tumours from complex and mixed tumours because spindle cells were seen in both 28% of the simple tumours and 39.3% of the complex or mix tumours. In conclusion, we believe that fine-needle aspiration cytology of canine mammary tumours is a valuable diagnostic tool, although our results indicated lower accuracy when inadequate samples were taken into consideration.
RESumEnEn este estudio se evaluaron en forma retrospectiva las características clínicas y patológicas de 155 perras con tumores mamarios. 55% de los animales con tumores mamarios eran Poodle (83 pacientes). La edad promedio al momento de la excisión del tumor fue de 10,3 ± 0,2 años, mientras que el tiempo transcurrido entre la detección del tumor y tratamiento del paciente fue de 308 ± 38,5 días. 46 de las 119 perras habían parido al menos una vez y 22 de 59 habían presentado un historial con falsa preñez. Además, 2% de los animales habían presentado tumores de origen vulvar o vaginal. 212 tumores fueron removidos quirúrgicamente y de ellos, 78,3% eran malignos, 12,3% resultaron benignos, 8% eran cambios hiperplásicos y 1,4% eran tumores no clasificados. No hubo asociación significativa entre el tipo histopatológico de los tumores mamarios y edad, raza, ubicación y duración del tumor, estado reproductivo, historial de preñez o pseudopreñez.
Endometrial adenocarcinoma is described in two young intact female Persian cats presented with haemorrhagic vaginal discharge. The discharge had been present for 3 and 15 days in each case, respectively. On the basis of signalment, history, clinical, laboratory and diagnostic imaging findings a tentative diagnosis of pyometra was made in each cat and ovariohysterectomy was subsequently performed. Histological examination revealed endometrial adenocarcinoma in both cats together with ovarian luteal cysts and pyometra in one case. Immunohistochemistry revealed a diffuse and strongly positive reaction for oestrogen receptors in the nuclei of glandular epithelium in well-differentiated areas of the neoplastic tissue. Poorly differentiated areas of solid growth pattern had weak and focal expression of oestrogen receptors. Furthermore, the neoplastic cells within these areas displayed moderate to strong diffuse nuclear staining with Ki-67 antibody suggestive of a high proliferative capacity. The owners reported that the cats were clinically healthy 23 and 21 months after the surgery. These cases highlight the importance of histological examination of surgically resected tissue even when clinical signs and laboratory findings suggest pyometra.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.